BDBM50067632 3-{3-[4-(Benzothiazol-2-yl-methyl-amino)-piperidin-1-yl]-propyl}-2-(3,5-di-tert-butyl-4-hydroxy-phenyl)-thiazolidin-4-one::CHEMBL137094
SMILES: CN(C1CCN(CCCN2C(SCC2=O)c2cc(c(O)c(c2)C(C)(C)C)C(C)(C)C)CC1)c1nc2ccccc2s1
InChI Key: InChIKey=JQMDACVTWFQSGE-UHFFFAOYSA-N
Data: 1 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Calcium channel (RAT) | BDBM50067632 (3-{3-[4-(Benzothiazol-2-yl-methyl-amino)-piperidin...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem | Article PubMed | n/a | n/a | 230 | n/a | n/a | n/a | n/a | n/a | n/a |
Chugai Pharmaceutical Company, Ltd. Curated by ChEMBL | Assay Description In vitro inhibition of K+ induced contractions of the isolated rat aorta. | J Med Chem 41: 4309-16 (1998) Article DOI: 10.1021/jm980335f BindingDB Entry DOI: 10.7270/Q23N22JV | |||||||||||
More data for this Ligand-Target Pair |